225 related articles for article (PubMed ID: 26861725)
21. Editorial: Formulation and Delivery of Biologics.
Besheer A; Mahler HC
Pharm Res; 2020 Oct; 37(11):225. PubMed ID: 33078256
[No Abstract] [Full Text] [Related]
22. Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.
Ruge CA; Kirch J; Lehr CM
Lancet Respir Med; 2013 Jul; 1(5):402-13. PubMed ID: 24429205
[TBL] [Abstract][Full Text] [Related]
23. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary drug delivery: medicines for inhalation.
Henning A; Hein S; Schneider M; Bur M; Lehr CM
Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
[TBL] [Abstract][Full Text] [Related]
25. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
Wang YB; Watts AB; Peters JI; Williams RO
Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
[TBL] [Abstract][Full Text] [Related]
26. Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals-The Outcome of a Cross-Industry Working Group Survey.
Wolfreys A; Kilgour J; Allen AD; Dudal S; Freke M; Jones D; Karantabias G; Krantz C; Moore S; Mukaratirwa S; Price M; Tepper J; Cauvin A; Manetz S; Robinson I
Toxicol Pathol; 2021 Feb; 49(2):261-285. PubMed ID: 33535023
[TBL] [Abstract][Full Text] [Related]
27. Design control considerations for biologic-device combination products.
Anderson D; Liu R; Anand Subramony J; Cammack J
Adv Drug Deliv Rev; 2017 Mar; 112():101-105. PubMed ID: 28088344
[TBL] [Abstract][Full Text] [Related]
28. Support for the revocation of general safety test regulations in biologics license applications.
Evans DM; Thorn JM; Arch-Douglas K; Sperry JB; Thompson B; Davis HL; McCluskie MJ
Biologicals; 2016 May; 44(3):178-81. PubMed ID: 26996102
[TBL] [Abstract][Full Text] [Related]
29. Current approaches to the discovery of novel inhaled medicines.
Strong P; Ito K; Murray J; Rapeport G
Drug Discov Today; 2018 Oct; 23(10):1705-1717. PubMed ID: 29775668
[TBL] [Abstract][Full Text] [Related]
30. Inhaled Medicines: Past, Present, and Future.
Anderson S; Atkins P; Bäckman P; Cipolla D; Clark A; Daviskas E; Disse B; Entcheva-Dimitrov P; Fuller R; Gonda I; Lundbäck H; Olsson B; Weers J
Pharmacol Rev; 2022 Jan; 74(1):48-118. PubMed ID: 34987088
[TBL] [Abstract][Full Text] [Related]
31. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements.
Badkar AV; Gandhi RB; Davis SP; LaBarre MJ
Drug Des Devel Ther; 2021; 15():159-170. PubMed ID: 33469268
[TBL] [Abstract][Full Text] [Related]
33. Back to the future: inhaled drug products.
Hickey AJ
J Pharm Sci; 2013 Apr; 102(4):1165-72. PubMed ID: 23381932
[TBL] [Abstract][Full Text] [Related]
34. Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption.
Sakagami M
Ther Deliv; 2013 Dec; 4(12):1511-25. PubMed ID: 24304249
[TBL] [Abstract][Full Text] [Related]
35. Treating systemic diseases via the lung.
Sanjar S; Matthews J
J Aerosol Med; 2001; 14 Suppl 1():S51-8. PubMed ID: 11424894
[TBL] [Abstract][Full Text] [Related]
36. Inhaled nanoparticles--a current review.
Yang W; Peters JI; Williams RO
Int J Pharm; 2008 May; 356(1-2):239-47. PubMed ID: 18358652
[TBL] [Abstract][Full Text] [Related]
37. Correlation and clinical relevance of animal models for inhaled pharmaceuticals and biopharmaceuticals.
Sécher T; Bodier-Montagutelli E; Guillon A; Heuzé-Vourc'h N
Adv Drug Deliv Rev; 2020 Dec; 167():148-169. PubMed ID: 32645479
[TBL] [Abstract][Full Text] [Related]
38. Oral delivery of biologics using drug-device combinations.
Caffarel-Salvador E; Abramson A; Langer R; Traverso G
Curr Opin Pharmacol; 2017 Oct; 36():8-13. PubMed ID: 28779684
[TBL] [Abstract][Full Text] [Related]
39. Systemic delivery of drugs to humans via inhalation.
Gonda I
J Aerosol Med; 2006; 19(1):47-53. PubMed ID: 16551214
[TBL] [Abstract][Full Text] [Related]
40. Protein & Peptide Drug Delivery - Third International Conference. Minimally invasive delivery methods. 22-23 September 2003, Philadelphia, PA, USA.
Kochendoerfer G
IDrugs; 2003 Nov; 6(11):1043-5. PubMed ID: 15270035
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
